T. Iwaki et al., AN IMMUNOHISTOCHEMICAL STUDY OF TISSUE TRANSGLUTAMINASE IN GLIOMAS WITH REFERENCE TO THEIR CELL DYING PROCESSES, The American journal of pathology, 145(4), 1994, pp. 776-781
Tissue transglutaminase is a Ca2+-dependent enzyme that catalyzes the
formation of protein cross-links by an acyl transfer reaction. Recent
reports have suggested that tissue transglutaminase is induced by tumo
r progression and apoptosis. In this study we immunohistochemically in
vestigated a series of gliomas by using an antiserum against a dodecap
eptide from the COOH-terminal of tissue transglutaminase. Among the gl
iomas the presence of positive immunoreactivity tended to increase in
malignant counterparts. It is also noteworthy to mention that glioblas
toma cells surrounding the zonal necrosis in a palisade fashion were s
trongly immunolabeled The degenerating products in tumor cells, such a
s round granulated bodies, were primarily immunopositive, whereas Rose
nthal fibers were negative. Dying cells through apoptosis in the metas
tatic brain tumors could be easily recognized by the presence of tissu
e transglutaminase. In conclusion, tissue transglutaminase may therefo
re be valuable in the prognostic characterization of gliomas with resp
ect to the detection of dying cells. However, the appearance of tissue
transglutaminase-positive neoplastic cells tons not limited to apopto
tic bodies but could also be detected in necrobiotic cell nests.